Global Dravet Syndrome Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 161091
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 120
  • list Pharmaceuticals and Healthcare

Dravet syndrome is a rare, severe form of intractable epilepsy. It occurs due to a mutation in the SCN1A gene, which is required for the proper function of brain cells.

Scope of the Report:

Although there is no cure for Dravet syndrome, most treatments aim to reduce seizures. First line anti-seizure medications include clobazam (Onfi, Frisium) and valproic acid (Depakote, Depakene). Second line treatments include stiripentol (Diacomit), topiramate (Topamax), and the ketogenic diet.

The worldwide market for Dravet Syndrome Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Dravet Syndrome Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Biocodex

Epygenix Therapeutics

GW Pharmaceuticals

OPKO Health

Zogenix

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

First-generation Drug (FGD)

Second-generation Drug (SGD)

Third-generation Drug (TGD)

Market Segment by Applications, can be divided into

Hospital Pharmacy

Retail Pharmacy

E- Commerce

Others

There are 15 Chapters to deeply display the global Dravet Syndrome Treatment market.

Chapter 1, to describe Dravet Syndrome Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Dravet Syndrome Treatment, with sales, revenue, and price of Dravet Syndrome Treatment, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Dravet Syndrome Treatment, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Dravet Syndrome Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Dravet Syndrome Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Dravet Syndrome Treatment Introduction

1.2 Market Analysis by Type

1.2.1 First-generation Drug (FGD)

1.2.2 Second-generation Drug (SGD)

1.2.3 Third-generation Drug (TGD)

1.3 Market Analysis by Applications

1.3.1 Hospital Pharmacy

1.3.2 Retail Pharmacy

1.3.3 E- Commerce

1.3.4 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Biocodex

2.1.1 Business Overview

2.1.2 Dravet Syndrome Treatment Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Biocodex Dravet Syndrome Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Epygenix Therapeutics

2.2.1 Business Overview

2.2.2 Dravet Syndrome Treatment Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Epygenix Therapeutics Dravet Syndrome Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 GW Pharmaceuticals

2.3.1 Business Overview

2.3.2 Dravet Syndrome Treatment Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 GW Pharmaceuticals Dravet Syndrome Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 OPKO Health

2.4.1 Business Overview

2.4.2 Dravet Syndrome Treatment Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 OPKO Health Dravet Syndrome Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Zogenix

2.5.1 Business Overview

2.5.2 Dravet Syndrome Treatment Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Zogenix Dravet Syndrome Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Dravet Syndrome Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Dravet Syndrome Treatment Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Dravet Syndrome Treatment Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Dravet Syndrome Treatment Manufacturer Market Share in 2017

3.3.2 Top 6 Dravet Syndrome Treatment Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Dravet Syndrome Treatment Market Analysis by Regions

4.1 Global Dravet Syndrome Treatment Sales, Revenue and Market Share by Regions

4.1.1 Global Dravet Syndrome Treatment Sales and Market Share by Regions (2013-2018)

4.1.2 Global Dravet Syndrome Treatment Revenue and Market Share by Regions (2013-2018)

4.2 North America Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

4.3 Europe Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

4.5 South America Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

5 North America Dravet Syndrome Treatment by Countries

5.1 North America Dravet Syndrome Treatment Sales, Revenue and Market Share by Countries

5.1.1 North America Dravet Syndrome Treatment Sales and Market Share by Countries (2013-2018)

5.1.2 North America Dravet Syndrome Treatment Revenue and Market Share by Countries (2013-2018)

5.2 United States Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

5.3 Canada Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

5.4 Mexico Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

6 Europe Dravet Syndrome Treatment by Countries

6.1 Europe Dravet Syndrome Treatment Sales, Revenue and Market Share by Countries

6.1.1 Europe Dravet Syndrome Treatment Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Dravet Syndrome Treatment Revenue and Market Share by Countries (2013-2018)

6.2 Germany Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

6.3 UK Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

6.4 France Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

6.5 Russia Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

6.6 Italy Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

7 Asia-Pacific Dravet Syndrome Treatment by Countries

7.1 Asia-Pacific Dravet Syndrome Treatment Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Dravet Syndrome Treatment Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Dravet Syndrome Treatment Revenue and Market Share by Countries (2013-2018)

7.2 China Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

7.3 Japan Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

7.4 Korea Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

7.5 India Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

8 South America Dravet Syndrome Treatment by Countries

8.1 South America Dravet Syndrome Treatment Sales, Revenue and Market Share by Countries

8.1.1 South America Dravet Syndrome Treatment Sales and Market Share by Countries (2013-2018)

8.1.2 South America Dravet Syndrome Treatment Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

8.3 Argentina Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

8.4 Colombia Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

9 Middle East and Africa Dravet Syndrome Treatment by Countries

9.1 Middle East and Africa Dravet Syndrome Treatment Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Dravet Syndrome Treatment Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Dravet Syndrome Treatment Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

9.3 UAE Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

9.4 Egypt Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

9.5 Nigeria Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

9.6 South Africa Dravet Syndrome Treatment Sales and Growth Rate (2013-2018)

10 Global Dravet Syndrome Treatment Market Segment by Type

10.1 Global Dravet Syndrome Treatment Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Dravet Syndrome Treatment Sales and Market Share by Type (2013-2018)

10.1.2 Global Dravet Syndrome Treatment Revenue and Market Share by Type (2013-2018)

10.2 First-generation Drug (FGD) Sales Growth and Price

10.2.1 Global First-generation Drug (FGD) Sales Growth (2013-2018)

10.2.2 Global First-generation Drug (FGD) Price (2013-2018)

10.3 Second-generation Drug (SGD) Sales Growth and Price

10.3.1 Global Second-generation Drug (SGD) Sales Growth (2013-2018)

10.3.2 Global Second-generation Drug (SGD) Price (2013-2018)

10.4 Third-generation Drug (TGD) Sales Growth and Price

10.4.1 Global Third-generation Drug (TGD) Sales Growth (2013-2018)

10.4.2 Global Third-generation Drug (TGD) Price (2013-2018)

11 Global Dravet Syndrome Treatment Market Segment by Application

11.1 Global Dravet Syndrome Treatment Sales Market Share by Application (2013-2018)

11.2 Hospital Pharmacy Sales Growth (2013-2018)

11.3 Retail Pharmacy Sales Growth (2013-2018)

11.4 E- Commerce Sales Growth (2013-2018)

11.5 Others Sales Growth (2013-2018)

12 Dravet Syndrome Treatment Market Forecast (2018-2023)

12.1 Global Dravet Syndrome Treatment Sales, Revenue and Growth Rate (2018-2023)

12.2 Dravet Syndrome Treatment Market Forecast by Regions (2018-2023)

12.2.1 North America Dravet Syndrome Treatment Market Forecast (2018-2023)

12.2.2 Europe Dravet Syndrome Treatment Market Forecast (2018-2023)

12.2.3 Asia-Pacific Dravet Syndrome Treatment Market Forecast (2018-2023)

12.2.4 South America Dravet Syndrome Treatment Market Forecast (2018-2023)

12.2.5 Middle East and Africa Dravet Syndrome Treatment Market Forecast (2018-2023)

12.3 Dravet Syndrome Treatment Market Forecast by Type (2018-2023)

12.3.1 Global Dravet Syndrome Treatment Sales Forecast by Type (2018-2023)

12.3.2 Global Dravet Syndrome Treatment Market Share Forecast by Type (2018-2023)

12.4 Dravet Syndrome Treatment Market Forecast by Application (2018-2023)

12.4.1 Global Dravet Syndrome Treatment Sales Forecast by Application (2018-2023)

12.4.2 Global Dravet Syndrome Treatment Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Dravet Syndrome Treatment Picture

Table Product Specifications of Dravet Syndrome Treatment

Figure Global Sales Market Share of Dravet Syndrome Treatment by Types in

Please fill the form below, to recieve the report sample


+1